ER-alpha 36, a Variant of ER-alpha, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

No Thumbnail Available
Authors
Lin, Sheng-Li
Yan, Li-Ying
Zhang, Xin-Tian
Yuan, Ju
Li, Mo
Qiao, Jie
Wang, Zhao-Yi
Sun, Qing-Yuan
Issue Date
2010
Type
Journal Article
Language
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways
Abstract
Description
Citation
Lin, Sheng-Li; Yan, Li-Ying; Zhang, Xin-Tian; Yuan, Ju; Li, Mo; Qiao, Jie; Wang, Zhao-Yi; Sun, Qing-Yuan. ER-alpha 36, a Variant of ER-alpha, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways. Plos One. 2010, FEB 2. 5(2):e9013-e9013.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
1932-6203
1932-6203
EISSN